Medicine
Lidocaine 1000 mg/50 mL injection
Lidocaine 1000 mg/50 mL injection is a generic prescription medicine for infiltration use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
All solutions should be stored at 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Lidocaine
- Brand
- Sold under the generic name
- Strength
- 1000 mg/50 mL
- Dosage form
- Injection
- Route
- Infiltration
- Packs
- 25 vials of 50 mL
- Manufacturer
- Anthea PharmaIndia
- Origin register
- US FDA, United States
- Storage
- All solutions should be stored at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BB01 Lidocaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 9 April 2025
- Identifiers
- RxCUI 1010033, 1010671, 1737562 +4DailyMed set ID 240c4744-e58c-4c08-93ad-8d6418c4f8a9NDC 83854-010Application ANDA219535
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 50 mL in 1 vial | 83854-010-27 | Anthea PharmaIndia | 6 February 2026 |
| 25 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 31722-217-32 | — | 13 December 2023 |
| 10 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 31722-217-33 | — | 13 December 2023 |
| 25 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 55150-256-50 | — | 30 October 2017 |
| 10 vial in 1 carton / 50 mL in 1 vial | 70756-667-10 | — | 24 October 2023 |
| 25 vial in 1 carton / 50 mL in 1 vial | 70756-667-25 | — | 24 October 2023 |
| 1 vial in 1 carton / 50 mL in 1 vial | 70756-667-90 | — | 24 October 2023 |
| 10 vial, multi-dose in 1 package / 50 mL in 1 vial, multi-dose | 0143-9575-10 | — | 14 February 1972 |
| 25 vial, multi-dose in 1 tray / 50 mL in 1 vial, multi-dose | 0409-4277-02 | — | 19 August 2005 |
| 50 mL in 1 vial, multi-dose | 51662-1326-1 | — | 22 October 2018 |
| 50 mL in 1 vial, multi-dose | 51662-1384-1 | — | 18 October 2019 |
| 10 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 50 mL in 1 vial, multi-dose | 51662-1384-3 | — | 14 July 2022 |
| 25 pouch in 1 case / 1 vial, multi-dose in 1 pouch / 50 mL in 1 vial, multi-dose | 51662-1590-3 | — | 13 July 2022 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 71872-7095-1 | — | 26 February 2019 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 71872-7156-1 | — | 26 February 2019 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 71872-7256-1 | — | 30 June 2021 |
| 1 vial, multi-dose in 1 package / 50 mL in 1 vial, multi-dose | 50090-3366-0 | — | 8 February 2018 |
| 1 vial, multi-dose in 1 bag / 50 mL in 1 vial, multi-dose | 0404-9797-50 | — | 28 May 2025 |
| 10 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 72603-825-10 | — | 1 February 2025 |
| 25 vial, multi-dose in 1 carton / 50 mL in 1 vial, multi-dose | 72603-825-25 | — | 1 February 2025 |
| 50 mL in 1 vial, multi-dose | 84549-277-02 | — | 10 October 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 19 November 1948 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lidocaine 1000 mg/50 mL injection.
Other strengths and forms of Lidocaine
Clinical summary
Lidocaine is an amide local anesthetic. It is available as injection, ointment and patches for infiltration, perineural and topical use. MedsAcross supplies Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LidocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xylocaine prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Lidocaine 1000 mg/50 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.